Troy A. Ignelzi insider trades

Open-market stock purchases and sales by Troy A. Ignelzi, Director at Contineum Therapeutics, Inc, from SEC Form 4 filings since Jan 17, 2018.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +265%.

Recent trades

DateStockTradeValue
Jun 26, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Apr 2, 2026HRMY Harmony Biosciences Holdings, IncBought (not open market)—
Feb 2, 2026RAPP Rapport Therapeutics, IncBought (not open market)—

Companies traded

  • CTNM Contineum Therapeutics, Inc: other filings, last Jun 26, 2026
  • HRMY Harmony Biosciences Holdings, Inc: other filings, last Apr 2, 2026
  • RAPP Rapport Therapeutics, Inc: 2 buys, last Feb 2, 2026
  • KRTX Karuna Therapeutics, Inc: 51 sales, last Aug 22, 2023
  • CINC CinCor Pharma, Inc: other filings, last Feb 24, 2023
  • SCPH scPharmaceuticals Inc: other filings, last Jan 17, 2018

Get free alerts when Troy A. Ignelzi files a new trade →